
Myriad Genetics MYGN
€ 3.10
-0.28%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Myriad Genetics EV 2011-2026 | MYGN
EV Jährlich Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 598 M | 1.2 B | 2.03 B | 2 B | 2.3 B | 1.86 B | 2.38 B | 3.07 B | 1.96 B | 2.23 B | 2.44 B | 2.82 B | 2.4 B | 2.16 B | 1.9 B | 1.66 B | 3.39 B | -238 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.39 B | -238 M | 2.01 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.29 | -20.63 % | $ 1.72 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.93 | -1.61 % | $ 482 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 112.11 | -1.0 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
463 M | $ 19.08 | 1.06 % | $ 553 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
15.3 B | $ 140.65 | -1.81 % | $ 22.4 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 19.81 | -3.32 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 93.98 | -2.78 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 419.51 | 0.08 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 046.9 | 0.48 % | $ 21.6 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.28 | -1.02 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 155.13 | -2.51 % | $ 7.69 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
432 M | $ 18.58 | -1.85 % | $ 416 M | ||
|
Natera
NTRA
|
5.53 B | $ 187.34 | -4.86 % | $ 18.4 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 25.34 | -0.65 % | $ 24 B | ||
|
Guardant Health
GH
|
15.2 B | $ 93.18 | -5.56 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.73 | -1.63 % | $ 239 M | ||
|
Personalis
PSNL
|
380 M | $ 6.5 | -3.2 % | $ 580 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 117.79 | 0.6 % | $ 9.72 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.99 | - | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 252.4 | -0.64 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 441.45 | -1.49 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.57 | -1.7 % | $ 205 M | ||
|
Celcuity
CELC
|
5.57 B | $ 134.95 | 0.17 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 48.89 | -7.67 % | $ 2.92 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 8.28 | -1.78 % | $ 1.8 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 332.25 | -0.29 % | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 186.87 | -0.57 % | $ 20.7 B |